ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,545,000 | +74.3% | 59,663 | +11.7% | 0.85% | +75.3% |
| Q3 2021 | $3,181,000 | -42.8% | 53,414 | -34.5% | 0.48% | -43.1% |
| Q2 2021 | $5,565,000 | +31.1% | 81,599 | +33.4% | 0.85% | +14.1% |
| Q1 2021 | $4,244,000 | +276.6% | 61,166 | +317.1% | 0.75% | +186.2% |
| Q4 2020 | $1,127,000 | +135.3% | 14,663 | +128.7% | 0.26% | +82.5% |
| Q3 2020 | $479,000 | +80.8% | 6,411 | +52.5% | 0.14% | +60.7% |
| Q2 2020 | $265,000 | – | 4,203 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |